🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT06585267
Active, not recruiting Observational

Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis

NCT06585267 · tracked via the Priya Life Science UK tracker
Sponsor
Invibio Ltd
Phase
Observational
Started
2024-10-07
Last updated
2026-09-09

Condition(s) studied

Complete Questionnaires Following TKR Surgery

Study summary

Development of a new Patient Reported Outcome Measure (PROM) to assess patient's emotional wellbeing, and perceptions of Total Knee Replacement surgery for the treatment of knee arthritis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18 years of age or older. * Patients who have undergone Total Knee Replacement surgery with a metal implant for the treatment of end-stage knee arthritis in the last 3 months. * Patients who have only undergone one Total Knee Replacement surgery on the index knee. * Patients who, in the opinion of the Investigator, are able to understand this project and co-operate with the requirements of participation. * Patients who are able to give voluntary, written informed consent to participate in this project and from whom consent has been obtained. Exclusion Criteria: * Patients, who in the opinion of the Investigator, exhibit evidence of any condition or co-morbidity that would compromise their participation in the project. * Patients who are unable to understand and communicate fluently in English. * Patients who have experienced a complication following Total Knee Replacement surgery requiring a further hospital admission or revision surgery to the index knee.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chapel Allerton Hospital Leeds United Kingdom
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06585267 on ClinicalTrials.gov ↗ ← All trials in the UK